Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

Figure 8

Optimum region identified by overlaying plots of friability and disintegration time as functions of PEG 6000 and crospovidone at 10.6 kN compression force.